Literature DB >> 7505690

Genotype analysis of adult cystic fibrosis patients.

C Férec1, C Verlingue, H Guillermit, I Quéré, O Raguénès, J Feigelson, M P Audrézet, P Moullier, B Mercier.   

Abstract

To assess the relationship between the genotype and phenotype of adult CF patients we have selected from a group of 512 CF patients attending centres in France, all these of greater than 35 years. We have analysed the entire coding sequence of their CFTR genes. The complete genotype was determined in 7 of the 8 patients and clinical data regarding pancreatic, respiratory and reproductive function were carefully evaluated. All these patients are compound heterozygote, seven carrying the delta F508 and one the G542X on one allele. The other allele carried is: (i) a missense mutation located in exons coding for transmembrane region in five patients [R334W (1); I336K (2); R117H (1); H1054D (1)]; (ii) a splice mutation in two patients [2789 + 5G-->A], (iii) an uncharacterised mutations in one patient. These results strongly suggest less severe CF phenotype to be associated with these mutations and strengthen the hypothesis that less severe phenotype are genetically determined.

Entities:  

Mesh:

Substances:

Year:  1993        PMID: 7505690     DOI: 10.1093/hmg/2.10.1557

Source DB:  PubMed          Journal:  Hum Mol Genet        ISSN: 0964-6906            Impact factor:   6.150


  6 in total

1.  Identification of cystic fibrosis transmembrane conductance regulator channel-lining residues in and flanking the M6 membrane-spanning segment.

Authors:  M Cheung; M H Akabas
Journal:  Biophys J       Date:  1996-06       Impact factor: 4.033

2.  Blood concentrations of pancreatitis associated protein in neonates: relevance to neonatal screening for cystic fibrosis.

Authors:  J Sarles; S Barthellemy; C Férec; J Iovanna; M Roussey; J P Farriaux; A Toutain; J Berthelot; N Maurin; J P Codet; P Berthézène; J C Dagorn
Journal:  Arch Dis Child Fetal Neonatal Ed       Date:  1999-03       Impact factor: 5.747

3.  Neonatal screening for cystic fibrosis: result of a pilot study using both immunoreactive trypsinogen and cystic fibrosis gene mutation analyses.

Authors:  C Férec; C Verlingue; P Parent; J F Morin; J P Codet; G Rault; M Dagorne; A Lemoigne; H Journel; M Roussey
Journal:  Hum Genet       Date:  1995-11       Impact factor: 4.132

4.  A cluster of cystic fibrosis mutations in exon 17b of the CFTR gene: a site for rare mutations.

Authors:  B Mercier; W Lissens; G Novelli; L Kalaydjieva; M de Arce; N Kapranov; N Canki Klain; X Estivill; A Palacio; S Cashman
Journal:  J Med Genet       Date:  1994-09       Impact factor: 6.318

5.  Cystic Fibrosis Transmembrane Conductance Regulator (CFTR): CLOSED AND OPEN STATE CHANNEL MODELS.

Authors:  Valentina Corradi; Paola Vergani; D Peter Tieleman
Journal:  J Biol Chem       Date:  2015-07-30       Impact factor: 5.157

Review 6.  The Changing Epidemiology of Cystic Fibrosis: Incidence, Survival and Impact of the CFTR Gene Discovery.

Authors:  Virginie Scotet; Carine L'Hostis; Claude Férec
Journal:  Genes (Basel)       Date:  2020-05-26       Impact factor: 4.096

  6 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.